Casper Tind Hansen

Casper Tind Hansen

Casper has 15 years of expertise in pharma, biotech, and venture capital. He has taken on various roles in Marketing and Business Development at Lundbeck and Nycomed, he was part of the investment team at Novo Ventures, and has been CEO of Pcovery, a Danish Discovery stage biotech company. Casper Has been a co-founder of Orphazyme and Embark Biotech. He holds a M.Sc in Human Biology from the University of Copenhagen.